21 CFR § 20.62 - Inter- or intra-agency memoranda or letters.

---
identifier: "/us/cfr/t21/s20.62"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 20.62 - Inter- or intra-agency memoranda or letters."
title_number: 21
title_name: "Food and Drugs"
section_number: "20.62"
section_name: "Inter- or intra-agency memoranda or letters."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL"
part_number: "20"
part_name: "PUBLIC INFORMATION"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "5 U.S.C. 552; 18 U.S.C. 1905; 19 U.S.C. 2531-2582; 21 U.S.C. 321-393, 1401-1403; 42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, 300aa-1."
regulatory_source: "42 FR 15616, Mar. 22, 1977, unless otherwise noted."
cfr_part: "20"
---


# 20.62 Inter- or intra-agency memoranda or letters.

Interagency or intra-agency memoranda or letters that would not be available by law to a party other than an agency in litigation with the Food and Drug Administration may be withheld from public disclosure except that factual information that is reasonably segregable in accordance with the rule established in § 20.22 is available for public disclosure. The deliberative process privilege shall not apply to records created 25 years or more before the date on which the records were requested.

[87 FR 55913, Sept. 13, 2022]